Taysha Gene Therapies, Inc.
TSHA • NASDAQ
Taysha Gene Therapies, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean Nolan, with a market cap of $1.2B.
Market Cap$1.2B
Employees52.0
CEOSean Nolan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Taysha Gene Therapies, Inc. FAQ
Common questions about Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $758.3K.
Taysha Gene Therapies, Inc. has approximately 52 employees.